FibroBiologics (FBLG) Share-based Compensation (2023 - 2026)
FibroBiologics (FBLG) reported Share-based Compensation of $707,000 for Q2 2026, down 3.0% from $729,000 a year earlier but up 1.9% from the prior quarter.
Powered by 
Analysis
FibroBiologics (FBLG) Share-based Compensation (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, FibroBiologics' Share-based Compensation came in at $2.81 million, up 17.2% year-over-year; for FY2025, it came in at $2.69 million, up 21.0% from FY2024.
- Share-based Compensation has increased for three consecutive years, with a three-year compound annual growth rate of 151.9% (FY2022 to FY2025).
- By year, Share-based Compensation came in at $2.22 million in FY2024 (+25.7%), $1.77 million in FY2023 (+950.6%) and $168,000 in FY2022.
- Five-year quarterly Share-based Compensation spans a low of $432,000 in Q4 2023 and a high of $729,000 in Q2 2025.
- Year over year, Share-based Compensation gained in seven of the last eight quarters, with growth averaging 20.4%.
- The high point for year-over-year Share-based Compensation in five years was Q3 2024 (growth of 30.9%); the low point was Q2 2026 (a decline of 3.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $694,000 (Q1 2026), $702,000 (Q4 2025) and $704,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | FibroBiologics | 8.66 Mn | 8.66 Mn | - | 707,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 707,000.00 |
| Mar 31, 2026 | 694,000.00 |
| Dec 31, 2025 | 702,000.00 |
| Sep 30, 2025 | 704,000.00 |
| Jun 30, 2025 | 729,000.00 |
| Mar 31, 2025 | 551,000.00 |
| Dec 31, 2024 | 544,000.00 |
| Sep 30, 2024 | 572,000.00 |
| Jun 30, 2024 | 578,000.00 |
| Mar 31, 2024 | 525,000.00 |
| Dec 31, 2023 | 432,000.00 |
| Sep 30, 2023 | 437,000.00 |
| Jun 30, 2023 | 448,000.00 |
| Mar 31, 2023 | 448,000.00 |
API Access
FibroBiologics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FBLG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "FBLG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FBLG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();